Advertisement

Topics

Comparative determinants of 5-year cardiovascular event rates in patients with unprotected left main coronary artery disease.

08:00 EDT 1st August 2017 | BioPortfolio

Summary of "Comparative determinants of 5-year cardiovascular event rates in patients with unprotected left main coronary artery disease."

Diabetes mellitus (DM), low ejection fraction (EF), and the extent of coronary artery disease (CAD) have all been identified as predictors of cardiovascular events in multivessel disease, but their comparative contributions to future risk remain unclear in patients with unprotected left main coronary artery (ULMCA) disease. Through this study we aimed to categorize the risk for cardiovascular events in patients with ULMCA disease using simple clinical descriptors.

Affiliation

Journal Details

This article was published in the following journal.

Name: Coronary artery disease
ISSN: 1473-5830
Pages: 387-394

Links

DeepDyve research library

PubMed Articles [38821 Associated PubMed Articles listed on BioPortfolio]

Coronary artery calcification predicts cardiovascular complications after sepsis.

Sepsis is a highly prevalent and fatal condition, with reported cardiovascular event rates as high as 25-30% at 1year. Risk stratification in septic patients has been extremely limited.

Medication Synchronization Programs Improve Adherence To Cardiovascular Medications And Health Care Use.

Medication synchronization programs based in pharmacies simplify the refill process by enabling patients to pick up all of their medications on a single visit. This can be especially important for imp...

Persistent smoking after a cardiovascular event: A nationwide retrospective study in Korea.

Smoking is a major risk factor of cardiovascular disease (CVD) such as stroke and ischemic heart disease. Prior studies have observed people continued smoking even after being diagnosed with CVD. Howe...

Association between triglyceride levels and cardiovascular disease in patients with acute pancreatitis.

Conventional wisdom supports prescribing "fibrates before statins", that is, prioritizing treatment of hypertriglyceridemia (hTG) to prevent pancreatitis ahead of low-density lipoprotein cholesterol t...

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.

Background Degludec is an ultralong-acting, once-daily basal insulin that is approved for use in adults, adolescents, and children with diabetes. Previous open-label studies have shown lower day-to-da...

Clinical Trials [8497 Associated Clinical Trials listed on BioPortfolio]

Predicting Physical Activity Change: an Epidemiologic Study

To conduct a two-year follow up of participants in a cross-sectional study of physical activity determinants. Predictors of change in vigorous exercise habits and recreational walking hab...

Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia

Acetylsalicylic acid (Aspirin, ASA) is the most widely prescribed drug used in primary and secondary prevention of cardiovascular disease. However, aspirin resistance has been described, m...

Genetic and Environmental Determinants of Hypertension

To determine the pathophysiology of different types of essential hypertension by identifying the discrete effects of major genes and environmental variables as determinants of the subtypes...

HIV and Cardiovascular Risk

HIV-infected patients treated with combination antiretroviral therapy demonstrate metabolic abnormalities that may predispose them to cardiovascular disease. In HIV-infected patients we w...

Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program

The primary objective of this study is to identify whether cardiovascular complication rates are lower in patients who participate in managed diabetes care, in comparison to provincial and...

Medical and Biotech [MESH] Definitions

A specialty concerned with the nursing care of patients suffering from disorders of the CARDIOVASCULAR SYSTEM as well as those identified as at risk for adverse cardiac or vascular events.

Restoration of functions to the maximum degree possible in a person or persons suffering from a CARDIOVASCULAR DISEASE. It also includes cardiac conditioning and SECONDARY PREVENTION in patients with elevated cardiovascular risk profile.

Conduct and synthesis of systematic research comparing interventions and strategies to prevent, diagnose, treat, and monitor health conditions. The purpose of this research is to inform patients, providers, and decision-makers, responding to their expressed needs, about which interventions are most effective for which patients under specific circumstances. (hhs.gov/recovery/programs/cer/draftdefinition.html accessed 6/12/2009)

The proportion of patients with a particular disease during a given year per given unit of population.

Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.

Advertisement
Quick Search
Advertisement
Advertisement

 


DeepDyve research library

Relevant Topics

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...


Searches Linking to this Article